Lee Johnson Capital Management LLC Acquires New Position in iShares U.S. Pharmaceuticals ETF $IHE

Lee Johnson Capital Management LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 18,493 shares of the company’s stock, valued at approximately $1,603,000. Lee Johnson Capital Management LLC owned approximately 0.17% of iShares U.S. Pharmaceuticals ETF as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of IHE. Stratos Wealth Advisors LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at approximately $555,000. D.A. Davidson & CO. acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at approximately $1,709,000. Prevail Innovative Wealth Advisors LLC bought a new position in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $4,529,000. Accurate Wealth Management LLC bought a new position in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $6,372,000. Finally, Childress Capital Advisors LLC bought a new position in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $1,018,000.

iShares U.S. Pharmaceuticals ETF Price Performance

iShares U.S. Pharmaceuticals ETF stock opened at $91.88 on Monday. iShares U.S. Pharmaceuticals ETF has a 12 month low of $64.46 and a 12 month high of $95.60. The company has a fifty day moving average price of $89.67 and a two-hundred day moving average price of $87.79. The company has a market cap of $992.30 million, a PE ratio of 17.75 and a beta of 0.50.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.